Flow Motion, the End of Stop and Go the Most Advanced
PET/CT in India
This is the era of Fusion imaging i.e fusing the functional information with the anatomical images. The functional information gives us the metabolic status of the particular organ whereas anatomical images provides us with the structural/morphological changes
Here at SRMS FIMC, we have got one of the most advanced fusion imaging modality in the form of Biograph mCT Flow PET-CT scanner which for the first time in this part of world, can provide us the most detailed information about any functional abnormality in the human body; basically in oncology but not limited to; with some diseases of neurology and cardiac origin as well.
Using Flow Motion Technology
Overcome Today’s PET/CT Challenges
Until now, PET examinations have been performed in sequential bed positions, alternating between acquisition and patient table motion. As such, image quality and quantitative accuracy have always been restricted, and scans often resulted in higher dose and greater patient anxiety. Powered by Siemens’ revolutionary FlowMotion technology, Biograph mCT Flow is the world’s first PET/CT system to eliminate the demand for stop-and-go imaging.
With Flow Motion examinations, parameters such as speed, image resolution and motion management can be easily adjusted to the precise dimensions of organs and routinely
FlowMotion technology eliminates overlapping bed acquisitions while maintaining uniform noise sensitivity across the entire scan range, enabling
FlowMotion allows easy anatomy-based scan planning where only the desired area is scanned.
Biograph mCT Flow is the first-and-only PET•CT to combine a large 78 cm bore with Flow Motion’s
continuous sense of scan progress, offering the
Finest Volumetric Resolution
Biographm mCT Flow with its OptisoHD detection system optimizes each component of the imaging chain.In addition to that, this comes with single source dual-energy CT capabilities for improved lesion contrast.
Virtually Freeze Motion
Through an innovative combination of hardware and software, HDoChest virtually freezes respiratory motion, enabling full HD lesion detection and accurate standard uptake value (SUV) quantification.The five-year survival rate for NSCLC may more than double if caught earlier, benefiting up to 85% of lung cancer patients. 3FlowMotion simplifies integration of HDoChest into every scan.
Precise Organ Imaging
Examination parameters such as speed, image resolution and motion management can be easily adjusted to the precise dimensions of organs.
Hi-Rez Increases Accuracy
Improved accuracy can change patient management in up to 40% of head and neck cancer cases.4 FlowMotion technology additionally provides simple incorporation of Hi-Rez into the PET scan protocols. This PET reconstruction with the industry’s highest1400x400 matrix can increase resolution potentially resulting in improved detection.
Assessment of myocardial viability in patients with Ischaemic Heart Disease and poor left ventricular function being considered for revascularization in combination with perfusion imaging with sestamibi/tetrofosmin/ thallium.
Assessment of activity and distribution of disease at baseline in highly selected cases where there is diagnostic uncertainty using conventional imaging (e.g. suspected cardiac sarcoidosis). Assessment of disease response where other measures to monitor response are unhelpful and/or in patients with disease resistant to treatment.
Evaluation of suspected vasculitis in selected cases; for example, to determine the extent & distribution of the disease activity.
Pyrexia of unknown origin (PUO)
To identify the cause of a PUO where conventional investigations have not revealed a source.